The efficacy of vitamin E in reducing non-alcoholic fatty liver …
网页2020年12月7日 — Vitamin E was superior at improving alanine aminotransferase (ALT), aspartate aminotransferase (AST), NAFLD activity score (NAS), and fibrosis in short- and long-term follow up in the adult population, and long-term follow up in the pediatric population. Improvements in metabolic outcomes were best noticed in pediatric patients.
Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver ...
网页2020年7月6日 — Vitamin E is a potent antioxidant useful for the management of NAFLD. Our systematic review suggests that vitamin E helps improve several biochemical and histological derangements in NAFLD. However, it does not seem to improve some important aspects of NAFLD disease pathology such as hepatic fibrosis.
Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: …
网页2018年1月16日 — In addition to the role of being an antioxidant, some studies have also proposed that vitamin E improves the liver integrity by down-regulating hepatic cluster of differentiation 36 protein (CD36)—a membrane transporter responsible for the uptake of fatty acids into the liver .
Vitamin E intake is inversely associated with NAFLD measured by …
网页2024年1月31日 — Vitamin E as an antioxidant has a protective potential in NAFLD. Whether dietary intake of vitamin E, supplementary vitamin E use, and total vitamin E have a preventive effect on...
Systematic review with meta‐analysis: The effect of vitamin E ...
网页2020年8月18日 — Vitamin E reduced the values of liver enzymes compared with placebo (−7.37 IU/L, 95% confidence interval: −10.11 to −4.64 for alanine aminotransferase, and −5.71 IU/L, 95% confidence interval: −9.49 to −1.93 for aspartate aminotransferase).
The association between vitamin E intake and hepatic steatosis in ...
网页2024年7月30日 — Using data from the National Health and Nutrition Examination Survey (NHANES) and employing Controlled Attenuation Parameter (CAP) measures, this study explores the correlation between vitamin E (VE) intake and hepatic steatosis and its impact on different subsets. Materials and methods.
Vitamin E supplementation in the treatment on nonalcoholic fatty …
网页2023年7月28日 — Vitamin E administration improves ALT, AST, fibrosis, and steatosis in NAFLD subjects. Fibrosis scores were significantly reduced when vitamin E dosage exceeded 600 IU/day or with a treatment duration of at least 12 months. CONFLICT OF INTEREST. The authors declare that they have no conflict of interest. Supporting Information. REFERENCES.
Vitamin E for fatty liver: Benefits, management, and FAQs
网页2023年3月3日 — Vitamin E is an important fat-soluble vitamin that has antioxidant and anti-inflammatory properties. These properties positively impact fatty liver disease, but research is inconclusive. As its...
Vitamin E improves serum markers and histology in adults with …
网页2024年8月16日 — This study aimed to assess the effect of vitamin E on serum markers of liver inflammation, specifically serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and histology, including resolution of metabolic dysfunction-associated steatohepatitis (MASH), in adult patients with MASLD.
Vitamin E for Fatty Liver in AASLD Guidelines - NATAP
网页Vitamin E (rrr α†tocopherol) administered at a daily dose of 800 IU/day improves liver histology in nondiabetic adults with biopsy†proven NASH and therefore may be considered for this patient population. Risks and benefits should be discussed with each patient before starting therapy. 28.